Company Synaptogenix, Inc. Other OTC
Equities
SNPX
US87167T1025
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 17-12-31 |
Daniel Alkon
PSD | President | 81 | 20-12-06 |
Robert Weinstein
DFI | Director of Finance/CFO | 64 | 13-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 17-12-31 |
Bruce Bernstein
BRD | Director/Board Member | 60 | 16-11-13 |
Joshua Silverman
CHM | Chairman | 53 | 16-08-03 |
Director/Board Member | 50 | 18-12-12 | |
William Singer
BRD | Director/Board Member | 82 | 13-08-22 |
Daniel Alkon
PSD | President | 81 | 20-12-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,085,333 | 1,058,910 ( 97.57 %) | 0 | 97.57 % |
Stock B | 0 | 6,000 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |